Cytochromes P450 are Expressed in Proliferating Cells in Barrett's Metaplasia

Hughes, Steven J; Morse, Mark A; Weghorst, Christopher M; Kim, Hyesook; Watkins, Paul B; Guengerich, F Peter; Orringer, Mark B; Beer, David G
June 1999
Neoplasia;Jun/Jul99, Vol. 1 Issue 2, p145
Academic Journal
The expression of cytochromes P450 (CYP) in Barrett's esophagus and esophageal squamous mucosa was investigated. Esophagectomy specimens from 23 patients were examined for CYP expression of CYP1A2, CYP3A4, CYP2C9/10, and CYP2E1 by immunohistochemical analysis, and the expression of CYP1A1, CYP3A4, CYP1B1, CYP2E1, and CYP2C9/10 in these tissues was further confirmed by reverse transcription polymerase chain reaction. Immunohistochemical analysis of esophageal squamous mucosa (n = 12) showed expression of CYP1A2, CYP3A4, CYP2E1, and CYP2C9/10 proteins, but it was noted that cells within the basal proliferative zone did not express CYPs. Immunohistochemical analysis of Barrett's esophagus (n = 13) showed expression of CYP1A2, CYP3A4, CYP2E1, and CYP2C9/10 that was prominent in the basal glandular regions, which are areas containing a high percentage of actively proliferating cells. Immunohistochemical staining for both proliferating cell nuclear antigen and the CYPs further supported the colocalization of CYP expression to areas of active cell proliferation in Barrett's esophagus, whereas in the esophageal squamous epithelium, CYP expression is limited to cells that are not proliferating. RT-PCR with amplification product sequence analysis confirmed CYP1A1, CYP3A4, CYP1B1, CYP2E1, and CYP2C9/10 mRNA expression in Barrett's esophagus. These data suggest that the potential ability of cells in Barrett's esophagus to both activate carcinogens and proliferate may be important risk factors affecting carcinogenesis in this metaplastic tissue.


Related Articles

  • Expression and Effect of Inhibition of the Ubiquitin-Conjugating Enzyme E2C on Esophageal Adenocarcinoma. Lin, Jules; Raoof, Duna A.; Zhuwen Wang; Mu-Yen Lin; Thomas, Dafydd G.; Greenson, Joel K.; Giordano, Thomas J.; Orringer, Mark B.; Chang, Andrew C.; Beer, David G.; Lin Lin // Neoplasia;Dec2006, Vol. 8 Issue 12, p1062 

    Ubiquitin-dependent proteolysis of cyclins plays a critical role in cell cycle progression and tumorigenesis. We examined the expression of ubiquitin-conjugating enzyme E2C (UBE2C) during progression from Barrett's metaplasia to esophageal adenocarcinoma (EA) and the effects of targeting this...

  • Role of Proton Pump Inhibitor on Esophageal Carcinogenesis and Pancreatic Acinar Cell Metaplasia Development: An Experimental In Vivo Study. Dall’Olmo, Luigi; Fassan, Matteo; Dassie, Elisa; Scarpa, Marco; Realdon, Stefano; Cavallin, Francesco; Cagol, Matteo; Battaglia, Giorgio; Pizzi, Marco; Guzzardo, Vincenza; Franceschinis, Erica; Pasut, Gianfranco; Rugge, Massimo; Zaninotto, Giovanni; Realdon, Nicola; Castoro, Carlo // PLoS ONE;Nov2014, Vol. 9 Issue 11, p1 

    Chronic gastro-duodenal reflux in the esophagus is a major risk for intestinal metaplasia and Barrett’s adenocarcinoma. A role for chronic use of proton pump inhibitor (PPI) in the increased incidence of esophageal adenocarcinoma in Western countries has been previously suggested. The aim...

  • Esophageal Cancer Prevention in Zinc-Deficient Rats Rapid Induction of Apoptosis by Replenishing Zinc. Fong, Louise Y.Y.; Nguyen, Vu T.; Farber, John L. // JNCI: Journal of the National Cancer Institute;10/17/2001, Vol. 93 Issue 20, p1525 

    Investigates the role of zinc deficiency on the development of esophageal tumors. Identification of cytochrome enzymes; Observation of the apoptotic cells; Indication of nuclear antigen.

  • SURVEY OF CURRENT CLINICAL PRACTICE IN THE DIAGNOSIS, MANAGEMENT AND SURVEILLANCE OF BARRETT'S METAPLASIA: A UK NATIONAL SURVEY. Ishaq, S.; Harper, E.; Brown, J.; Moayyedi, P.; Wicks, T.; Watson, P.; Barr, H.; Attwood, S.; Harrison, R.; Jankowski, J. // Gut;Apr2003 Supplement 1, Vol. 52, pA32 

    Introduction: Barrett's metaplasia (BM) is the precursor lesion for oesophageal adenocarcinoma, a tumour with a rising incidence and a uniformly poor prognosis. In spite of the recognition of this fact and the almost exponential increase in clinical and basic science research, much uncertainty...

  • Reduced expression of Axin correlates with tumour progression of oesophageal squamous cell carcinoma. Nakajima, M; Fukuchi, M; Miyazaki, T; Masuda, N; Kato, H; Kuwano, H // British Journal of Cancer;6/2/2003, Vol. 88 Issue 11, p1734 

    Axin is a negative regulator of the Wnt signalling pathway, and genetic alterations of AXIN1 have been suggested to be an important factor of carcinogenesis in some tumours. The objective of this study was to clarify the clinicopathologic and prognostic significance of Axin in oesophageal...

  • Restoration of the Normal Squamous Lining in Barrett's Esophagus by Argon Beam Plasma Coagulation. Byrne, James P.; Armstrong, Gordon R.; Attwood, Stephen E. A. // American Journal of Gastroenterology;Oct1998, Vol. 93 Issue 10, p1810 

    Objective: Barrett's esophagus is associated with significantly increased risk of development of esophageal adenocarcinoma. Replacing columnar epithelium with the normal squamous lining in this condition offers the possibility of decreasing the risk of degeneration to invasive adenocarcinoma....

  • THE IMPORTANCE OF CYTOKERATINS 7 AND 20 IMMUNOHISTOCHEMISTRY IN THE DISTINCTION OF GASTRO-ESOPHAGEAL ADENOCARCINOMAS. Voinescu, Doina-Carina; Comanescu, Violeta; Popescu, Carmen; Cruce, M. // Annals of the Romanian Society for Cell Biology;2009, Vol. 14 Issue 2, p144 

    The gastro-esophageal junction is regularly exposed to concentrated gastric acid and to a variety of nitrosating species, noxious agents that may contribute to carcinogenesis in this region. Adenocarcinomas of the gastric cardia and distal oesophagus are among the most deadly of all...

  • The Incidence of Adenocarcinoma in Barrett's Esophagus: A Prospective Study of 170 Patients Followed 4.8 Years. Drewitz, D. J.; Sampliner, R. E.; Garewal, H. S. // American Journal of Gastroenterology;Feb1997, Vol. 92 Issue 2, p212 

    Objectives: Barrett's esophagus is a premalignant condition defined by the presence of intestinal metaplasia in the esophagus. Estimates of the incidence of adenocarcinoma developing in patients with Barrett's esophagus vary widely. We prospectively followed a cohort of patients to define the...

  • Role of retinoid X receptor mRNA expression in Barrett's esophagus Brabender, Jan; Lord, Reginald V.; Metzger, Ralf; Park, JiMin; Salonga, Dennis; Danenberg, Kathleen D.; Hölscher, Arnulf H.; Danenberg, Peter V.; Schneider, Paul M.; Hölscher, Arnulf H // Journal of Gastrointestinal Surgery;May2004, Vol. 8 Issue 4, p413 

    The Barrett''s multistage process is characterized histopathologically by progression from Barrett''s intestinal metaplasia to Barrett''s esophagus with dysplasia and ultimately adenocarcinoma. Understanding of the molecular alterations in this multistage process may contribute to improved...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics